BC Week In Review | Dec 9, 2013
Company News

Becton Dickinson sales and marketing update

Becton's BD Diagnostics unit launched its BD Max StaphSR Assay in the U.S. to detect Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). The assay, which has CE Mark approval and is available in Europe, identifies...
BC Week In Review | Sep 9, 2013
Company News

Becton Dickinson sales and marketing update

Becton's BD Diagnostics unit launched its BD Max StaphSR Assay in Europe to detect Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). The assay, which has CE Mark approval, identifies S. aureus and MRSA from nasal...
BC Week In Review | Jul 16, 2012
Clinical News

BD Max MRSA Assay regulatory update

Becton's BD Diagnostics segment said it received FDA clearance for BD Max MRSA Assay to identify patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) from nasal swabs. The in vitro diagnostic, which is performed on the...
Items per page:
1 - 3 of 3